20/20 Biolabs (AIDX) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


20/20 Biolabs, Inc.  (Nasdaq: AIDX)
    Sector • Technology    Industry • IT Infrastructure
   Industry • IT Infrastructure
   Sector • Technology

20/20 Biolabs Profitability Comparisons

Select each Category to receive further Information




AIDX Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 41.71 % 46.5 % 57.31 % 38.76 %
Gross Margin (Q2 TTM) 32.07 % 46.17 % 56.78 % 38.1 %
Gross Profit Margin 5 Yr. Avg. - 45.13 % 46.02 % 26.63 %
EBITDA Margin (Q2 MRQ) 75.67 % 27.07 % 41.77 % 22.29 %
EBITDA Margin (Q2 TTM) 50.79 % 23.75 % 36.75 % 20.86 %
EBITDA Margin 5 Yr. Avg. - 9.91 % 23.7 % 11.84 %
Operating Margin (Q2 MRQ) -170.31 % 19.47 % 28.71 % 16.03 %
Operating Margin (Q2 TTM) -198.15 % 17.55 % 27.15 % 16.33 %
Operating Margin 5 Yr. Avg. - --6.77 % 15.67 % 8.21 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 18.04 % 33.67 % 13.95 %
Pre-Tax Profit Margin (Q2 TTM) 0 % 16.02 % 29.18 % 13.1 %
Pre-Tax Profit Margin 5 Yr. Avg. - - 16.35 % 8.29 %
Net Margin (Q2 MRQ) -360.13 % 15.77 % 29.04 % 11.42 %
Net Margin (Q2 TTM) -295.07 % 13.06 % 24.33 % 10.76 %
Net Margin 5 Yr. Avg. - - 13.75 % 6.33 %



Business Segment Profit Margin
 
CLI Ax
  Explore CLI Ax Segment  -
One Test
  Explore One Test Segment  -
Bio Check
  Explore Bio Check Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) -82.87 % 20.43 % 14.91 % 9.55 %
Free Cash Flow Margin (Q2 TTM) -153.06 % 17.36 % 20.8 % 9.24 %
Free Cash Flow Margin 5 Yr. Avg. - 10.63 % 18.55 % 9.05 %
Net Cash Flow Margin (Q2 MRQ) 0 % 29.99 % 9.47 % 2.2 %
Net Cash Flow Margin (Q2 TTM) 0 % 4.86 % 2.24 % 1.79 %
Net Cash Flow Margin 5 Yr. Avg. - -11.85 % 0.89 % 1.4 %
Effective Tax Rate (Q2 MRQ) - 25.44 % 13.75 % 18.77 %
Effective Tax Rate (Q2 TTM)